CANNOPHEN will be a substitute for patients being treated with medical cannabis by smoking. Key indications will include chronic pain syndromes and Fibromyalgia, inter alia. Key advantages of this delivery form over smoking medical cannabis are metered and controlled dosage, fast and effective absorption and ease of use with no hazardous smoke inhalation or adverse environmental effects or issues of passive smoking. The ability to manufacture CANNOPHEN under strict quality control and quality assurance standards is intrinsic to this dosage form and to the establishment of strict clinical standards.
News 
Market Data 
Discover 
AI
